Our non-invasive rapid antigen kit identifies an active COVID-19 infection using just a nose sample. Results are available within 15 minutes, with no laboratory testing required.
Based on the technical data we’ve gathered from analysing multiple LFT devices, ours is one of the most advanced non-invasive antigen LFT devices available. Our devices offer a high diagnostic specificity and diagnostic sensitivity. This allows identification of the virus from 14 days after initial exposure or after the onset of symptoms, while minimising the risk of false negative results.
